Frailties in multi-state models: Are they identifiable? Do we need them?

Statistical Methods in Medical Research

Volumn 24, Issue 6, 2015, Pages 675-692

  Putter, Hein ^a   Van Houwelingen, Hans C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

frailty; Markov renewal model; multi state model

Indexed keywords

ANALYSIS OF COVARIANCE; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CONTROLLED STUDY; DISTANT METASTASIS; FRAILTY; GENERAL PATHOLOGICAL PARAMETERS; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; UNIVARIATE ANALYSIS; BREAST TUMOR; FEMALE; HUMAN; MARKOV CHAIN; METASTASIS; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK; STATISTICAL MODEL; SURVIVAL ANALYSIS; TUMOR RECURRENCE;

BREAST NEOPLASMS; FEMALE; HUMANS; MARKOV CHAINS; MODELS, STATISTICAL; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RISK; SURVIVAL ANALYSIS;

EID: 84948426838     PISSN: 09622802     EISSN: 14770334     Source Type: Journal    
DOI: 10.1177/0962280211424665     Document Type: Article

References (27)

1. Klein JP, Keiding N, Copelan EA,. Plotting summary predictions in multistate survival models-probabilities of relapse and death in remission for bone-marrow transplantation patients. Stat Med 1993; 12: 2315-2332.
2. Keiding N, Klein JP, Horowitz MM,. Multi-state models and outcome prediction in bone marrow transplantation. Stat Med 2001; 20: 1871-1885.
3. Gentleman RC, Lawless JF, Lindsey JC, Yan P,. Multi-state Markov models for analysing incomplete disease history data with illustrations for HIV disease. Stat Med 1994; 13: 805-821.
4. Alioum A, Commenges D, Thibaut R, Dabis F,. A multistate approach for estimating the incidence of human immunodeficiency virus by using data from a prevalent cohort study. J R Stat Soc Ser C Appl Stat 2005; 54: 739-752.
5. Sweeting MJ, De Angelis D, Aalen OO,. Bayesian back-calculation using a multi-state model with application to HIV. Stat Med 2005; 24: 3991-4007.
6. Broet P, de la Rochefordiere A, Scholl SM, Fourquet A, De Rycke Y, Pouillart P, et al. Analyzing prognostic factors in breast cancer using a multistate model. Breast Cancer Res Treat 1999; 54: 83-89.
7. Putter H, van der Hage J, de Bock GH, Elgalta R, van de Velde CJH,. Estimation and prediction in a multi-state model for breast cancer. Biom J 2006; 48: 366-380.
8. Andersen PK, Keiding N,. Multi-state models for event history analysis. Stat Methods Med Res 2002; 11: 91-115.
9. Putter H, Fiocco M, Geskus RB,. Tutorial in biostatistics: Competing risks and multistate models. Stat Med 2007; 26: 2389-2430.
10. Andersen PK, Pohar Perme M,. Inference for outcome probabilities in multi-state models. Lifetime Data Anal 2008; 14: 405-431.
11. Meira-Machado L, de Uña Álvarez J, Cadarso-Suárez C, Andersen PK,. Multi-state models for the analysis of time-to-event data. Stat Methods Med Res 2009; 18: 195-222.
12. Aalen OO, Johansen S,. Empirical transition matrix for nonhomogeneous Markov-chains based on censored observations. Scand J Stat 1978; 5: 141-150.
13. Lagakos SW, Sommer CJ, Zelen M,. Semi-Markov models for partially censored data. Biometrika 1978; 65: 311-317.
14. Dabrowska DM, Sun GW, Horowitz MM,. Cox regression in a Markov renewal model: and application to the analysis of bone-marrow transplant data. J Am Stat Assoc 1994; 89: 867-877.
15. Aalen OO,. Dynamic description of a Markov chain with random time scale. Math Sci 1988; 13: 90-103.
16. Aalen OO, Borgan Ø Gjessing HK,. Survival and event history analysis, New York: Springer, 2008.
17. Bhattacharya M, Klein JP,. A random effects model for multistate survival analysis with application to bone marrow transplants. Math Biosci 2005; 194: 37-48.
18. Yen AMF, Chen THH, Duffy SW, Chen CD,. Incorporating frailty in a multi-state model: application to disease natural history modelling of adenoma-carcinoma in the small bowel. Stat Methods Med Res 2010; 19: 529-546.
19. Clahsen PC, van de Velde CJH, Julien JP, Floiras JL, Delozier T, Mignolet FY, et al. Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. J Clin Oncol 1996; 14: 745-753.
20. van der Hage JA, van de Velde CJH, Julien JP, Floiras JL, Delozier T, Vandervelden C, et al. Improved survival after one course of perioperative chemotherapy in early breast cancer patients: long-term results from the European Organization for Research and Treatment of Cancer (EORTC) Trial 10854. Eur J Cancer 2001; 37: 2184-2193.
21. Elbers C, Ridder G,. True and spurious duration dependence: the identifiability of the proportional hazard model. Rev Econ Stud 1982; XLIX: 403-409.
22. Perperoglou A, van Houwelingen HC, Henderson R,. A relaxation of the gamma frailty (Burr) model. Stat Med 2006; 25: 4253-4266.
23. Abbring JH, van den Berg GJ,. The identifiability of the mixed proportional hazards competing risks;[?tjl]?>model. J R Stat Soc Series B Stat Methodol 2003; 65: 701-710.
24. Di Serio C,. The protective impact of a covariate on competing failures with an example from a bone marrow transplantation study. Lifetime Data Anal 1997; 3: 99-122.
25. Nielsen GG, Gill RD, Andersen PK, Sørensen TIA,. A counting process approach to maximum likelihood estimation in frailty models. Scand J Stat 1992; 19: 25-43.
26. Bøvelstad HM, Nygård S, Størvold HL, Aldrin M, Borgan Ø Frigessi A, et al. Predicting survival from microarray data-a comparative study. Bioinformatics 2007; 23: 2080-2087.
27. Verweij PJM, van Houwelingen HC,. Cross-validation in survival analysis. Stat Med 1993; 12: 2305-2314.